|
US 11,938,176 B2 |
|
| Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers |
| Andrea Mahr, Tuebingen (DE); Toni Weinschenk, Aichwald (DE); Oliver Schoor, Tuebingen (DE); Jens Fritsche, Dusslingen (DE); Harpreet Singh, Munich (DE); and Colette Song, Ostfildern (DE) |
| Assigned to Immatics Biotechnologies GmbH, (DE) |
| Filed by Immatics Biotechnologies GmbH, Tuebingen (DE) |
| Filed on May 7, 2021, as Appl. No. 17/314,492. |
| Application 17/314,492 is a continuation of application No. 17/072,528, filed on Oct. 16, 2020. |
| Application 17/072,528 is a continuation of application No. 16/715,846, filed on Dec. 16, 2019, granted, now 10,835,586, issued on Nov. 17, 2020. |
| Application 16/715,846 is a continuation of application No. 16/367,790, filed on Mar. 28, 2019, granted, now 10,548,958, issued on Feb. 4, 2020. |
| Application 16/367,790 is a continuation of application No. 16/212,787, filed on Dec. 7, 2018, granted, now 10,314,899, issued on Jun. 11, 2019. |
| Application 16/212,787 is a continuation of application No. 15/978,700, filed on May 14, 2018, granted, now 10,213,498, issued on Feb. 26, 2019. |
| Application 15/978,700 is a continuation of application No. 15/799,495, filed on Oct. 31, 2017, granted, now 10,105,428, issued on Oct. 23, 2018. |
| Application 15/799,495 is a continuation of application No. 15/082,920, filed on Mar. 28, 2016, granted, now 9,931,388, issued on Apr. 3, 2018. |
| Claims priority of provisional application 62/140,767, filed on Mar. 31, 2015. |
| Claims priority of application No. 1505585 (GB), filed on Mar. 31, 2015. |
| Prior Publication US 2021/0275652 A1, Sep. 9, 2021 |
| Int. Cl. A61K 39/00 (2006.01); A61K 35/17 (2015.01); A61P 35/00 (2006.01); C07K 14/47 (2006.01); C07K 14/74 (2006.01); C07K 16/18 (2006.01); C07K 16/28 (2006.01); C07K 16/30 (2006.01); C12N 5/0783 (2010.01); C12N 15/115 (2010.01); G16B 25/00 (2019.01); G16B 25/10 (2019.01); A61K 35/12 (2015.01); C07K 14/705 (2006.01) |